Research

Estimates

SA Earngings
MB Earnings
Yahoo Earnings
CNBC Earnings
Barrons Earnings

Ratings

SA Ratings
MB Ratings
BC Ratings
TR Ratings
Fidelity

Short Interest

MB Shorts
Quandl

Smart Money

MB Institutional
Gurus

Options

BC Options Ratio

Financials

GuruFocus Summary

Social

Stocktwits
MB Social
SocialSentiment.com
Twitter
Yahoo
Facebook
Reuters
Google

Misc

Tickeron
Ycharts NAV +/-

Dyne Therapeutics, Inc. Common Stock | DYN

Daily Technical Analysis of Dyne Therapeutics, Inc. Common Stock

Dyne Therapeutics is down a bit on the day, funds flowing out kept the price down -1.60% since yesterday.

The Utilities company isn't at an immediate support or resistance level that might be predictive. Dyne Therapeutics hasn't established a very strong momentum in either direction over the last 3 months. We'll see if a stronger consensus among market participants emerges. DYN might find some support at the 13.93 level, buyers might push the price back up from here. But it's not very clear what will happen.


Last analyzed on 2024-11-13

Analyst Ratings for Dyne Therapeutics By Price Target And Rating

The analysts feel fairly neutral on the prospects for Dyne Therapeutics but a little more positive than negative. The current Analysts Sentiment Score is 11.13. Most companies range between (-200 to 200).

Here's a break down of the latest rating changes. On 2024-03-06 Stifel Nicolaus increased their price target by 17.14% to $41.00. Piper Sandler gave a boost to their price target and moved to $29.00 from $27.00 on 2024-03-06. On 2024-03-06 HC Wainwright reiterated their rating of Buy and added a price target of $36.00. Oppenheimer reiterated a rating of Outperform on 2024-03-05 and moved up their price target to $47.00 which is a 6.82% increase. Raymond James gave a boost to their price target and moved to $56.00 from $27.00 on 2024-01-04. JPMorgan Chase & Co. provided a price target boost of 10% to $22.00 from $20.00 on 2023-08-09. On 2023-08-04 there was confirmation of the previous rating by Chardan Capital which was Buy and added a price target of $20.00.

Company Ratings Score ?
Composite analyst sentiment score
Positive Ratings Negative Ratings Boost Price Target Lower Price Target
DYN11.1311.53010.720

Earnings Per Share (EPS) Estimates By Year and Quarter

(updated 2024-04-12)
Company YOY Growth Score (typical -20 to +20) Revision Directions (-6 to +6)
DYN0.000.00

Short interest for Dyne Therapeutics

We take into account several different measures of short interest to create a composite score. These measures are shown in the chart below. Short selling is when investors are betting against a stock. We compile these factors to create a dynamic Short Score - this can indicate poor sentiment, internal problems with a company or industry and the anticipation of future price declines. We look at the short interest percent, days to cover, the rate of change and total shares sold short.

Company Short Score (typical 1-15) ?
We take into account several different measures and attributes of short interest to create a composite sentiment score. typical range (0 - 30)
Short Interest Days to Cover Rate of Change Shares Short
DYN9.32%9.79-0.5942760000

How Dyne Therapeutics compares to the broader Utilities sector and the more specific Utilities - Independent Power Producers industry

Segment Count 1 Day% 5 Day 1 Month 3 Month 6 Month 1 Year RSI 3mo S-momo ? 6mo S-momo 1yr S-momo Resistance ? Support Demark Sell ? Demark Buy Short Interest Analysts Ratings ?
Utilities - Independent Power Producers

Show Me Companies With:

S-Momentum: Highest | Lowest
1 Day Growth: Highest | Lowest
5 Day Growth: Highest | Lowest
1 Month Growth: Highest | Lowest
6 Month Growth: Highest | Lowest
8-0.230.51-1.156.315.3480.2647.6226.1914.5329.72-19613.12-14618.920.000.005.581.13
Utilities

Show Me Companies With:

S-Momentum: Highest | Lowest
1 Day Growth: Highest | Lowest
5 Day Growth: Highest | Lowest
1 Month Growth: Highest | Lowest
6 Month Growth: Highest | Lowest
71-0.172.041.665.2612.6325.2957.6144.7927.8524.48-5606.43-14691.443.5211.623.650.95

Social Sentiment for Dyne Therapeutics

Social Sentiment is an aggregation of several different factors such as news, articles, blogs, user content, ratings, etc. Which is shown in the chart below. It may become predictive of a reversal if price and the sentiment diverge. Broader market forces may push prices up or down but if market participants maintain a different view on a specific stock, it may be taken as an opportunity to buy or sell in those cases.

Ticker Social Sentiment(1-10)
DYN

Companies with the highest correlation to Dyne Therapeutics

Company Score 1 Day% 5 Day 1 Month 3 Month 6 Month 1 Year RSI 3mo S-momo ? 6mo S-momo 1yr S-momo Resistance ? Support Demark Sell ? Demark Buy Short Interest Score
EXAS | Exact Sciences Corp0.71-0.636.16-24.22-15.885.08-19.9052.948.4517.92-4506.66-1214.26005.2321
RNA | Avidity Biosciences, Inc.0.71-2.570.83-5.72-0.2654.93587.047365.8295.41178.200.00-33401.690011.8771
NTLA | Intellia Therapeutics, In0.694.76-1.61-13.82-40.24-44.67-54.5861-82.93-57.08-57.19-41948.46-1911.170010.4627
SWTX | SpringWorks Therapeutics,0.68-1.201.4826.20-9.63-12.7278.6179-18.06-30.59-31.47-13150.98-3813.21150016.4437
PRO | Pros Holdings, Inc.0.681.150.1822.7413.84-26.92-36.8572-10.26-21.79-51.92-20330.83-3773.24150011.4181

Top 3 correlating companies

See full charts for all peers

Sentiment Score

How to use: use the research links to research the asset. Then simply type in a score for each category between (01, 02, 03, 04, 05). 05 being the most bullish and 01 being the most bearish. It will automatically calculate the average and combine it with the technical score to create an overall score to rank prospects by. You can also type notes into each field.

Earnings Estimates
Analyst Rating
Price Targets
Short Interest
Financials
Options Sentiment
Institutional Ownership
Social Sentiment
Fidelity Summary
Overall Summary Notes
Calculated Sentiment Sum

Score Sum
(1-45)

/

Average
(1-5)

+

Pattern Rank
(1-5)

=

Total Score
(1-10)

Research

Estimates

SA Earngings
MB Earnings
Yahoo Earnings

Ratings

SA Ratings
MB Ratings
BC Ratings
TR Ratings
Fidelity

Short Interest

MB Shorts
Quandl

Smart Money

MB Institutional
Gurus

Options

BC Options Ratio

Financials

GuruFocus Summary

Social

MB Social
SocialSentiment.com
Twitter
Yahoo
Facebook
Reuters
Google

Misc

Tickeron
Ycharts NAV +/-